On January 5, 2026, Moolec Science SA completed a 15-for-1 reverse stock split, consolidating every 15 ordinary shares into one. This adjustment reduced the total issued and outstanding share count from approximately 10.9 million to about 726,118 shares and increased the par value per share from US$0.10 to US$1.50. The consolidation was effected automatically without requiring any action from shareholders.

The decision to undertake the share consolidation followed resolutions adopted by shareholders at an extraordinary general meeting on December 16, 2025, and ratified by the board of directors on December 19, 2025. Those resolutions authorized management to execute the reverse split in order to enhance trading liquidity and address previous compliance concerns associated with low per-share values.

Following the reverse split, Moolec Science’s market capitalization stands at approximately US$3.12 million. Average daily trading volume on the Nasdaq exchange has been around 146,684 shares since the adjustment took effect. The company’s reduced float and higher per-share book value are expected to influence trading patterns and bid-ask spreads.

Management views the share consolidation as a strategic step to stabilize equity performance and bolster market perception. By raising the par value and reducing the share count, the company aims to attract institutional interest and improve eligibility for certain indices. Investors should monitor trading liquidity and post-split free-float metrics, as these will inform potential shifts in demand and valuation multiples.